We have previously demonstrated that sickle cell disease (SCD) patients maintain normal global systemic and cerebral oxygen delivery by increasing cardiac output. However, ischemic end-organ injury remains common suggesting that tissue oxygen delivery may be impaired by microvascular dysregulation or damage. To test this hypothesis, we performed fingertip laser Doppler flowmetry measurements at the base of the nailbed and regional oxygen saturation (rSO 2 ) on the dorsal surface of the same hand. This was done during flow mediated dilation (FMD) studies in 26 chronically transfused SCD, 75 nontransfused SCD, and 18 control subjects. Chronically transfused SCD patients were studied prior to and following a single transfusion and there was no acute change in rSO 2 or perfusion. Laser Doppler estimates of resting perfusion were 76% higher in nontransfused and 110% higher in transfused SCD patients, compared to control subjects.
Abstract
We have previously demonstrated that sickle cell disease (SCD) patients maintain normal global systemic and cerebral oxygen delivery by increasing cardiac output. However, ischemic end-organ injury remains common suggesting that tissue oxygen delivery may be impaired by microvascular dysregulation or damage. To test this hypothesis, we performed fingertip laser Doppler flowmetry measurements at the base of the nailbed and regional oxygen saturation (rSO 2 ) on the dorsal surface of the same hand. This was done during flow mediated dilation (FMD) studies in 26 chronically transfused SCD, 75 nontransfused SCD, and 18 control subjects. Chronically transfused SCD patients were studied prior to and following a single transfusion and there was no acute change in rSO 2 or perfusion. Laser Doppler estimates of resting perfusion were 76% higher in nontransfused and 110% higher in transfused SCD patients, compared to control subjects.
In contrast, rSO 2 was 12 saturation points lower in non-transfused SCD patients, but normal in the transfused SCD patients. During cuff occlusion, rSO 2 declined at the same rate in all subjects suggesting similar intrinsic oxygen consumption rates. Upon cuff release, laser doppler post occlusive hyperemia was blunted in SCD patients in proportion to their resting perfusion values. Transfusion therapy did not improve the hyperemia response. FMD was impaired in SCD subjects but partially ameliorated in transfused SCD subjects. Taken together, non-transfused SCD subjects demonstrate impaired conduit artery FMD, impaired microcirculatory post-occlusive hyperemia, and resting hypoxia in the hand despite compensated oxygen delivery, suggesting impaired oxygen supply-demand matching. Transfusion improves FMD and oxygen supply-demand matching but not microcirculation hyperemic response.
| INTRODUCTION
Sickle cell disease (SCD) is a common genetic disease resulting in the formation of hemoglobin S (HbS), which polymerizes upon deoxygenation. [1] [2] [3] HbS polymerization causes decreased red blood cell (RBC) deformability, intravascular hemolysis and increased vascular adhesion, promoting recurrent ischemia reperfusion injury and both large and small vessel disease. 3 Clinically, vascular disease manifests as acute vasocclusive pain episodes, stroke, chronic kidney disease, pulmonary hypertension and restrictive cardiomyopathy. [4] [5] [6] Chronic hemolysis, increased cellular adhesion, hypercoagulability, and increased blood viscosity act in concert, leading to diffuse vascular disease complications. 7 However, the SCD research community needs clinical measures of vascular disease that can act as surrogates for clinical outcomes, and be used as metrics for therapeutic trials.
Chronic inflammation and increased RBC adhesiveness in less deformable RBC leads to increased cellular adhesion and microvascular occlusion. This has been demonstrated in vitro, inanimal and in human intravital microscopy studies. [8] [9] [10] [11] [12] [13] Regional microvascular resistance in rat and mouse cremaster muscle initially increased after a bolus of SS RBC, but returned to levels within 20% of normal, due to recruitment of parallel vascular channels next to occluded capillaries.
However, microvascular dysfunction progressed after prolonged exposure to SS RBC. 12 Cellular adhesion limits blood flow in SCD microcirculation. This is by adhesion of reticulocytes and less deformable discoid RBC to endothelium in post-capillary venules and, in the precapillary arterioles 9, 13, 14 ; and RBC adherence to endothelium in the microcirculation likely correlates with clinical severity. 15 Multiple research groups have demonstrated decreased conduit artery flow-mediated dilation in sickle cell disease. [16] [17] [18] Our group linked impaired flow-mediated dilation (FMD) in the brachial artery with pulmonary hypertension in patients with sickle cell disease, and in patients with primary pulmonary hypertension. That suggests that endothelial dysfunction is a common precursor to both systemic and pulmonary vascular disease. 19, 20 We further demonstrated that cell free hemoglobin was the strongest predictor of FMD, consistent with its known role in nitric oxide (NO) scavenging and endothelial toxicity. 7, 21 However, the potential impact of hemolysis on more distal microvascular beds remains understudied.
In vivo characterization of the human microcirculation and regional hemoglobin oxygen saturation (%rSO 2 ) can be performed using laser protocol; all subjects were eight years of age or older. Patients were recruited from the hematology clinics at CHLA, USC and from the community. The non-transfused and healthy subjects were studied on a single visit (cross-sectional design). The chronically transfused subjects were studied immediately pre-transfusion and 12-h to 5-d post-transfusion.
Indications for chronic transfusion included abnormal transcranial Doppler (n = 9), prior stroke (n = 9), chronic pain (n = 2) or recurrent acute chest(n = 6). Chronically transfused patients had been regularly transfused at least 1.4 years (1.4-21.9 years). Any patients who had a history of acute crisis, defined as hospitalization or an emergency department visit with an increase or addition of pain medications above usual dosage, or a history of acute transfusion within the previous 4 wk, were temporarily deferred from study participation. Hydroxyurea use was documented based on patient report and medication effect was assessed by MCV measurements and presence or absence of HbF. Our cutoff to define HU responders was MCV > 100 fL/red cell or presence of HbF on electrophoresis. Some responders may reach an MCV less than 100 fL/red cell, depending on the MCV prior to HU initiation, but that data was not available in all subjects. We provided data on hemoglobin sub-type for the non-transfused subjects in order to be complete in our sample description. The hemoglobin subtype was not associated with any differences in vascular function for our sample, therefore, none of our analyses correct for the various subtypes. For laboratory, demographic, and vascular function data in the transfused group, we calculated a weighted average of the data that was collected pre-transfusion and post-transfusion.
| Flow-mediated dilation of the brachial artery
We used a flow-mediated dilation protocol with a 3-min cuff occlusion of the forearm and 7-min post ischemia monitoring period as previously described. 19 All vascular and oxygenation monitoring was performed during this testing procedure ( Figure S1 ). Using the forearm occlusion method, the published mean and SD for healthy subjects was 7.3% ± 0.9%. 28 For our combined vascular dysfunction metric we used a cutoff <6.3% based on our control FMD data, mean 7.5%, [95% CI 6.3% to 8.8%].
| Regional tissue hemoglobin oximetry (%rSO 2 )
We utilized a clinical near infrared spectroscopy cerebral/somatic regional oximetry monitor, Invos (Somanetics Corporation Troy, MI), for all regional oximetry monitoring. This measures the balance of oxygenated and deoxygenated hemoglobin in the tissue which includes both pre-capillary and post-capillary vasculature. A near infrared patch was placed on the dorsal surface of both hands. Regional tissue oximetry was sampled every 4 s for the duration of the study.
The cuff occlusion protocol includes baseline monitoring for at least 5-min, following a rest period of 10 min. Then cuff occlusion to >50 mmHg above systolic blood pressure was done for 3 min, and then release of the cuff with monitoring for 7-min post occlusion. 
| Venous blood samples for rheology and laboratory markers
Venous blood samples of~15 cc were drawn into EDTA tubes to assess markers of hemolysis, blood counts, hemoglobin electrophoresis, markers of inflammation, and blood rheology. Rheologic markers included blood viscosity measured over shear rates of 1 s −1 to 1000s
, and red blood cell deformability measured over shear stresses of 0.3 to 50 Pascals (Pa).
and Red cell aggregation was measured at stasis and low shear (3 s ), in a pro-aggregating dextran suspension (3% dextran 70 kDa in isotonic pH = 7.4 PBS buffer). Aggregation in plasma and in the dextran medium at 40% hematocrit was measured using the Myrenne aggregometer, (Myrenne GmbH, Roetgen, Germany). Blood viscosity was measured using an automatic tube viscometer (Rheolog, Health Vector Co., Pennsauken, NJ) as described previously. 29 Red blood cell deformability was measured using a laser diffraction ektacytometer LORRCA (Mechatronix, Inc., Amsterdam, NL) with a standardized diffraction pattern, consistent with our prior studies of deformability measurements in sickle cell disease.
30,31
| Statistical analysis
Data normality was determined by the Shapiro-Wilk test. We used parametric tests (Analysis of Variance) for normally distributed data and nonparametric tests (Kruskal-Wallis) for non-normally distributed data. Post hoc group comparisons were performed using the methods by Tukey and Steel with control for parametric and non-parametric data respectively. Due to controversy over metrics concerning hydroxyurea use and response, post hoc analysis of hydroxyurea data was performed using dichotomized variables: hydroxyurea (y/n) and hydroxyurea+MCV > 100 (y/n). We also used continuous variables for regression analysis: HbF% vs all vascular parameters. Paired statistics pre-transfusion and post-transfusion were performed using paired t test for parametric data and Wilcoxon Signed Rank Test for non-parametric data. Univariate and multivariate stepwise analyses were used to determine candidate variables for multivariate linear regression models. Area under the ROC curve was used to determine optimal cutoffs when determining continuous predictors of categorical variables. We combined all three groups and controlled for diagnosis/groupwise differences in the final models. All statistics were performed using JMP Pro version 13.0.0 (Copyright © 2016 SAS Institute Inc., Cary NC).
3 | RESULTS
| Patient characteristics
We enrolled 75 non-transfused patients, 26 chronically transfused (all homozygous SS) and 18 healthy subjects. Patient demographics are summarized in Table 1 . The transfused SCD group was younger than the non-transfused SCD and control groups (P = .002). The sex distribution was similar across the three groups. The SCD groups had elevated markers of inflammation and hemolysis compared to the control (P < .0001), independent of transfusion status. Chronic transfusion therapy improved but did not fully correct the anemia (P < .0001 comparing non-transfused and transfused by Tukey post hoc analysis, or Bonferroni correction for non-normal data). Laboratory markers of hemolysis, inflammation and anemia, and markers of vascular function (FMD, postocclusive hyperemia and %rSO 2 ) in non-transfused patients were independent of hydroxyurea use. This was true whether the comparison included all patients prescribed hydroxyurea, or was limited to good responders. Standard fingertip pulse oximetry was similar in all three groups, although there was a small subset of non-transfused patients with resting saturation in the high 1980s to mid-1990s on pulse oximetry.
adjusAments for low baseline pulse oximetry did not change our results.
| Effect of hydroxyurea on vascular parameters
Post hoc analysis of hydroxyurea use was performed using a dichotomous variable of hydroxyurea yes (y) or no (n) that was defined by two different methods. Abbreviations: LDH, lactate dehydrogenase; hs-CRP, high sensitivity C-reactive protein; SS, homozygous S form of sickle cell disease; SC, heterozygous for hemoglobin S and hemoglobin C; SF, number of patients with fetal hemoglobin present; SB, hemoglobin S-beta zero thalassemia. a P < .05 between patients and control subjects by Tukey post-hoc correction or Steel method with control. b P < .05 between transfused and nontransfused subjects by Tukey post-hoc correction or Steel method with control.
regional hemoglobin saturation, and flow-mediated dilation of the brachial artery between patients (data not shown).
| Acute effect of transfusion on resting hemoglobin saturation
There was no acute effect of a single transfusion on %rSO 2 and arterial blood is nearly completely saturated in both groups (Table 1) , peripheral oxygen delivery is increased in SCD patients. This implies that the decreased oxygen content (caused by the anemia and small differences in arterial oxygen saturation) is compensated by increased microvascular blood flow in the fingertip and, in some patients, increased above that which is expected for the degree of anemia.
If peripheral oxygen delivery is compensation for anemia, one would expect %rSO 2 to be normal. However, nontransfused SCD patients exhibited 12% lower (absolute percentage units) resting %rSO 2 value in the hand versuscontrol subjects ( Figure 2B ). In the chronically transfused group resting %rSO 2 was not different from control subjects. After cuff release, there is compensatory peripheral vasodilation caused by local products of tissue metabolism, leading to rebound hyperemia. Post occlusion, there was a trend toward increased absolute tissue perfusion by laser Doppler in both SCD groups compared to control (P = .06, data not shown). However, the percent increase in perfusion (post-occlusive hyperemia) was decreased compared to control in both transfused and non-transfused subjects ( Figure 2D ). to either model, it was a strong independent predictor of both %rSO 2 (deformability at shear stress >3 Pa) and FMD (deformability at shear stress >9 Pa), despite fewer subjects in each model (Table S2 ).
| FMD and %rSO 2

| DISCUSSION
We have previously demonstrated that while cardiac output and vital organ blood flow increase in patients with chronic anemia, the total oxygen delivery remains normal, consistent with Fick principles of oxygen transport. [32] [33] [34] [35] We postulated that regional oxygen delivery would be preserved as well in SCD patients, using laser Doppler flowmetry and % rSO 2 as surrogate biomarkers. In this study, we observed increased laser Doppler perfusion index, indicating that microvascular flow increases in the fingertip were compensatory and, in some patients, out of proportion to the anemia severity. Despite this, %rSO 2 in the hand was either normal (transfused subjects) or markedly decreased (non-transfused patients with an average 12% decrease in absolute hemoglobin saturation), suggesting either inefficient oxygen delivery or increased oxygen utilization. However, cuff occlusion studies did not suggest increased metabolic rate in SCD patients ( Figure S1 ), therefore, inefficient oxygen supplydemand matching is the most likely explanation. This is consistent with a previous finding by Waltz and colleagues that demonstrated normal muscle oxygen utilization and fatigue in patients with sickle cell disease. 36 The presence of surplus perfusion and inefficient oxygen delivery in the same limb is evidence of oxygen supply-demand mismatch, consistent with the review by Nath and colleagues. 37 Balancing of oxygen delivery to meet changing metabolic requirements is a complicated process. It is modulated by local metabolites, blood rheology, red cell biochemistry, and the autonomic nervous system, all of which are deranged in sickle cell disease. Others have described resting hyperemia in the face of microvascular pruning; [37] [38] [39] however, our simultaneous measures of conduit artery function, microvascular perfusion and %rSO 2 is the most complete assessment in a single study. Figure 1 In the present study, we Do not know if increased oxygen delivery and low %rSO 2 were present in the same capillary bed, because the near infrared and laser Doppler probes were in different locations. It is possible that T A B L E 2 Most robust models to predict regional hemoglobin oxygen saturation (%rSO 2 ) and flow-mediated dilation of the brachial artery (FMD)
Resting regional hemoglobin oxygen saturation (%rSO 2 ) vs X Model (n = 105, R 2 = 0.54, P < . Abbreviations: FMD, flow mediated dilation; hgb, hemoglobin. Note. Models including RBC deformability at various physiologic shear stress are included in the supplemental data.
arteriolarization was limited to the digits, causing a "steal" phenomenon that left the more proximal hand relatively underperfused. Regardless, this would still reflect a potentially dangerous derangement of oxygen supply demand matching in SCD patients.
Proper microvascular supply-demand matching is impacted by RBC deformability as demonstrated in Table S2 . Thus, RBC deformability is dependent on shear stress and physiologic shear stress in the vasculature ranges from~0.5 to 15 Pa, with some evidence that up to 30 Pa may exist. [44] [45] [46] We found that deformability at shear stress >2. acts as a sink that is able to store nitric oxide equivalents, whether it is nitrite or S-nitrosylated proteins, for use in remote areas of the vasculature and can convert nitrite to NO under low oxygen conditions. 54 Regional nitric oxide release inhibits platelet activation and aggregation, and could impact resting and hyperemic blood flow. 55 Some data implicate mechanical stress and RBC deformation as stimuli for local NO. 56 Our observation that RBC deformability is a powerful predictor of % rSO 2 is consistent with the findings of Charlot and colleagues 57 but cannot distinguish among these possible mechanisms.
Lastly, hemolysis products also disrupt oxygen supply-demand matching. Plasma free hemoglobin is a strong independent predictor of impaired FMD and %rSO 2 , suggesting that hemolysis impacts both conduit artery function and %rSO 2 , but not microcirculatory hyperperfusion at rest or post occlusion. Some of the FMD data in this study was previously published, but accrual of more patients strengthened the findings of that previous publication. Our in vivo, human vascular study protocol cannot demonstrate the mechanism of free hemoglobin scavenging of NO; however, the association of free hemoglobin with decreased FMD, in the setting of numerous in vitro, in-animal and in-human vascular models is strong evidence for NO dysregulation. Plasma free hemoglobin has been used in clinical trials as volume support in trauma patients.
However, it had multiple side effects, including raising mean arterial blood pressure, attributed to diffuse NO scavenging causing vasoconstriction. 58 Free hemoglobin decreases nitric oxide bioavailability through scavenging in the lumen and scavenging at the basement membrane. 7, 59, 60 Lastly, FMD is a specific test of shear mediated endothelial nitric oxide production and release when placing the cuff distal to the artery measured. 61 Thus, our finding of decreased FMD in patients with higher free hemoglobin points to impaired shear-mediated nitric oxide delivery to vascular smooth muscle. Decreased NO bioavailability could also potentially impair supply demand matching, by influencing vascular tone of pre-capillary arteriole sphincters.
Our data suggests that being female is protective, which is consistent with prior data examining sex specific changes in endothelial function and the nitric oxide metabolic pathways, particularly with regard to estrogen effects on endothelial nitric oxide synthase. 19, 32, 37, 62 We can postulate that this is one mechanism for improved female survival in sickle cell disease, especially with regard to the adult population. Since our study was focused on sickle cell disease and its associated vasculopathy, the ethnic makeup of our control group was similar to our patient population, 80-90% African-American and 10-20% Hispanic. It is known that nitric oxide dependent vascular function measures in conduit arteries (FMD) and the microcirculation (resting perfusion and PORH) are decreased in AfricanAmerican subjects without sickle cell disease 63 . Our data is consistent with that finding. Therefore, we do not believe differences in vascular function due to ethnicity affected our interpretation of the data.
Taken together, the vascular phenotype in SCD patients resembles conditions observed in sepsis or systemic inflammatory response syndrome (SIRS), although not acute or as severe. In these conditions, hypoxic multi-organ system failure occurs despite high organ blood flow. 64 Microvascular dysfunction is central to this process leading to functional arteriovenous shunting, impaired oxygen extraction, and vital organ hypoxia. 65 A study of trauma patients with sepsis demonstrated that impaired RBC deformability led to impaired oxygen utilization and a higher mixed venous oxygen saturation, which would be consistent with an increase in tissue shunting of blood flow. 66 Recent work has even implicated free heme in this process, as it increases pro-inflammatory macrophages leading to vascular/cellular damage. 67 Based on these observations, a mechanistic link involving plasma free hemoglobin and free heme is being drawn in sickle cell disease. Free heme induced vascular inflammation due to pro-inflammatory macrophage phenotypic change is ameliorated by hemopexin in a sickle mouse model. 68 Although SCD patients are not in distributive shock under normal conditions, they do exhibit high inflammatory tone, mild activation of coagulation pathways, increased sympathetic nervous system activity and increased circulating free hemoglobin and heme levels that mimic changes found in sepsis and SIRS. This demonstrates an important parallel in pathophysiology.
The clinical impact of these and previous findings cannot be understated. There is an acute on chronic vascular disease phenomenon occurring in patients with SCD, and the chronic vasculopathy is becoming more apparent as survival improves. All levels of the vasculature exhibit functional changes in patients with sickle cell disease, including conduit arteries, arterial microcirculation, venous microcirculation and the capillary bed [16] [17] [18] [19] 26, 40, 57, [69] [70] [71] leading to multiple organ dysfunction. Small vessel damage causes silent strokes in the brain, 72 pulmonary hypertension in the lungs, 73 and focal glomerular sclerosis in the kidney. 74 Recently, a cardiac phenotype of diffuse myocardial fibrosis and heart failure with preserved ejection fraction has been identified and linked to microangiopathy as well. 6, [75] [76] [77] In normal subjects, vital organs tolerate intermittent interruptions in oxygen delivery by increasing oxygen extraction and blood flow as well as redirecting flow from non-vital tissues. Our data suggest that all three of these compensatory mechanisms are impaired in SCD subjects and suggest a role for cell free hemoglobin and red cell deformability in their dysfunction.
Our study has several limitations.Seminal work by multiple SCD research groups have established the importance of vascular adhesion in microvascular dysfunction and we did not explore markers of cellular adhesion, which may play a major role in the LDF parameters that did not associate with free hemoglobin, FMD and %rSO 2 . [11] [12] [13] 69 The predictive value of our study is limited by the cross-sectional study design and correlative nature of the findings; however, our large sample size and inclusion of chronically transfused subjects studied pre and post transfusion improves the variability in our sample and predictive value of the results. Furthermore, our multi-modality approach allows us to simultaneously evaluate changes in vascular function at multiple levels of the vascular system while assessing blood and plasma biomarkers. The lack of acute change in regional hemoglobin oxygen saturation after transfusion may be because the oxygen saturation was normal to begin with, the measurement timing did not capture an increase, or the sample size was simply too small (P-value was 0.11).
Skin pigmentation may affect the NIRS measurement; however, given the ethnicity matching and occasional use of family members as control subjects, we assume that skin pigmentation would not affect our interpretation of the results. The mechanisms implied by our findings are consistent with previous work in animal and human models, however, these associations cannot prove causation, especially with regard to the pathophysiologic consequences of microcirculatory tissue oxygen supply-demand mismatch. Fortunately, these vascular testing procedures will allow us to directly test mechanisms non-invasively in a prospective fashion to evaluate their role in predicting outcomes, validate them as clinical biomarkers and test therapies.
| CONCLUSION
Our study addresses the critical problem of translating in-vitro, in-animal and in-vivo microvascular studies into simultaneous vascular assessment of the macrovasculature, microvasculature and resultant microcirculatory oxygen exchange in patients with sickle cell disease. Despite increased resting microcirculatory blood flow that compensates for anemia, tissue oxygen supply-demand mismatch persists in non-transfused patients but is ameliorated by chronic transfusion therapy. 
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